NVS - Novartis AG

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 202.90B
Enterprise Value 219.85B
Trailing P/E 29.79
Forward P/E 14.60
PEG Ratio (5 yr expected) 3.99
Price/Sales (ttm)4.03
Price/Book (mrq)3.91
Enterprise Value/Revenue 4.21
Enterprise Value/EBITDA 12.89

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 311.55%
S&P500 52-Week Change 33.90%
52 Week High 3105.56
52 Week Low 374.09
50-Day Moving Average 398.41
200-Day Moving Average 388.00

Share Statistics

Avg Vol (3 month) 32.21M
Avg Vol (10 day) 32.51M
Shares Outstanding 52.12B
Implied Shares Outstanding 6N/A
Float 820.06B
% Held by Insiders 10.01%
% Held by Institutions 18.25%
Shares Short (May 14, 2023) 44.28M
Short Ratio (May 14, 2023) 42.38
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 40.20%
Shares Short (prior month Apr 13, 2023) 45.5M

Dividends & Splits

Forward Annual Dividend Rate 43.5
Forward Annual Dividend Yield 43.60%
Trailing Annual Dividend Rate 33.46
Trailing Annual Dividend Yield 33.56%
5 Year Average Dividend Yield 43.56
Payout Ratio 4107.32%
Dividend Date 3Mar 19, 2023
Ex-Dividend Date 4Mar 08, 2023
Last Split Factor 21116:1000
Last Split Date 3Apr 08, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 13.45%
Operating Margin (ttm)25.47%

Management Effectiveness

Return on Assets (ttm)7.00%
Return on Equity (ttm)12.35%

Income Statement

Revenue (ttm)52.22B
Revenue Per Share (ttm)2.43
Quarterly Revenue Growth (yoy)3.10%
Gross Profit (ttm)36.74B
Net Income Avi to Common (ttm)7.03B
Diluted EPS (ttm)3.26
Quarterly Earnings Growth (yoy)3.20%

Balance Sheet

Total Cash (mrq)12.19B
Total Cash Per Share (mrq)0.58
Total Debt (mrq)29.2B
Total Debt/Equity (mrq)56.01
Current Ratio (mrq)1.05
Book Value Per Share (mrq)2.48

Cash Flow Statement

Operating Cash Flow (ttm)15.54B
Levered Free Cash Flow (ttm)11.48B